Paternal use of medications for inflammatory bowel disease and the risk of hospital‐diagnosed infections in the offspring: a nationwide cohort study

BACKGROUND: Information regarding the impact of paternal inflammatory bowel disease (IBD) medications on child outcomes is scarce. AIM: To examine the risk of childhood infections associated with fathers' use of anti‐inflammatory/immunosuppressive medications taken before conception. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Friedman, Sonia, Garvik, Olav Sivertsen, Nielsen, Jan, Nørgård, Bente Mertz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Effect of Paternal Use of IBD Medicines and Risk of Infection in Newborns
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542174/
https://www.ncbi.nlm.nih.gov/pubmed/35770457
http://dx.doi.org/10.1111/apt.17113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542174/
https://www.ncbi.nlm.nih.gov/pubmed/35770457
http://dx.doi.org/10.1111/apt.17113

Ejemplares similares